University of Illinois College of Medicine Peoria, IL
Eugene Annor, MD, MPH1, Oladoyin Jolaoye, DO2, Sonu Dhillon, MD2 1University of Illinois College of Medicine, Morton, IL; 2University of Illinois College of Medicine, Peoria, IL
Introduction: Colorectal cancer (CRC) is the third most common cancer in the United States and the second leading cause of cancer-related deaths. The USPTF guidelines recommend starting CRC screening at age 45. According to the CDC, in 2022, the rate of CRC screening among Caucasians was 74.6 %, and 75.3% among Blacks. Despite the high national screening rates, CRC screening remains suboptimal, with racial disparities still persisting. This study aims to evaluate CRC screening rates between Blacks and other racial groups from 2014 to 2023 across various ethnicities at a single academic tertiary healthcare system.
Methods: A retrospective analysis was conducted using Electronic Medical Records (EMR) data from patients aged 45-75 between 2014 to 2023 in an academic tertiary healthcare system in Illinois. The data reviewed included race, age, gender, and type of CRC screening. The CRC screening methods analyzed were Colonoscopy, fecal immunochemical test (FIT), and multitarget stool DNA test (sDNA-FIT).
Results: A total of 39,523 patients met the inclusion criteria. 86% were White, 9.5% were Black, 1.3% were Asian, and 3.1% were categorized as Native Hawaiian/Pacific Islander/Samoan/Unknown. 53.6% were females, and 46.4% were males, with a median age of about 59 years. 65.8% were screened via colonoscopy, 25.9% by FIT, and 8.2% were by sDNA-FIT. Among the Black patients, 64.8% had been screened via colonoscopy and were up to date with screening, compared to 66.2% of non-Hispanic White patients who had undergone colonoscopy colonoscopy and were current with their screening.
Discussion: At an academic tertiary healthcare system serving a population comprised of approximately 68.0% White, 19.0% Black, 4.0% Asian, and 5.7% Hispanic individuals, colonoscopy rates were similar between Blacks and non-Hispanic White patients, though the latter had a slightly higher screening rate. Nonetheless, these rates are still below the national average. Further research is needed to identify the barriers to successful CRC screening across different races and ethnicities.
Note: The table for this abstract can be viewed in the ePoster Gallery section of the ACG 2024 ePoster Site or in The American Journal of Gastroenterology's abstract supplement issue, both of which will be available starting October 27, 2024.
Disclosures:
Eugene Annor indicated no relevant financial relationships.
Oladoyin Jolaoye indicated no relevant financial relationships.
Sonu Dhillon indicated no relevant financial relationships.
Eugene Annor, MD, MPH1, Oladoyin Jolaoye, DO2, Sonu Dhillon, MD2. P0439 - Racial Differences in Colorectal Cancer Screening Rates in a Tertiary Healthcare System, ACG 2024 Annual Scientific Meeting Abstracts. Philadelphia, PA: American College of Gastroenterology.